Thomson Healthcare Launches Neonatal Drug Dosing Device
Posted on: Tuesday, 27 March 2007, 12:00 CDT
Thomson Healthcare, a provider of healthcare decision support systems designed to improve clinical and business performance outcomes, has launched a drug dosing system called NeoFax.
According to a recent study by the Institute of Medicine of the National Academies, medication errors injure more than 1.5 million people each year. Neonatal drug dosing and parenteral nutrition ordering are among the most complex and error-prone in hospital care.
The NeoFax system provides an infant drug and fluid nutrient dosing resource that contains alerts, an interaction checker and a patient-specific dosing calculator. The device contains more than 185 substances, as well as a set of clinical decision support modules for patient specific dosing and parenteral nutrition order entry for neonates.
NeoFax is available in print, PDA and as a web-based application for use in hospital neonatal intensive care units.
Source: Datamonitor
Related Articles
- Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results
- Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success
- Delcath to Present at the 12th Annual Drug Delivery Technologies & Deal Making Conference
- Celator(R) Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated With Therapy Based on Ratiometric Dosing
- Unit Dose Solutions Signs Five Hospital Systems for Drug Repackaging
- Neurocrine: FDA Raised Questions About Drug
- Failure to Mention Fixed-Dose Drug Combinations in the ATS/CDC/IDSA Tuberculosis Control Statement/From the Authors
- Chinese Firm Launches New Malaria Drug for Africa's Great Lakes Region
- Haul of "White Chinese" Drug Seized in Russian City of Pskov
- Pharmacogenetics As a Tool to Enable the Individualisation of Immunosuppressive Drug Treatment for Organ Transplantation
 |
 |
User Comments (0)
RSS Feeds